A20 is a tumor suppressor and a target gene of NF-κB, is biallelically inactivated in approximately 30% of DLBCL, and is mutated in the SUDHL2 and RC-K8 cell lines [28,31,32]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.